EUVIMEDEUVIMED entdecken
Crossref

Single nucleus RNA sequencing and functional in vivo studies reveal TCF21 as a protective regulator in cardiac fibrosis

Tousif Azmain iD, Doan Duy Hai Tran iD, Afifa Binta Saifuddin iD, Xingbo Xu iD, Fouzi Alnour iD, Gerd Hasenfuß, Melanie Hulshoff iD, Phillip L Eckhardt, Xiaoying Tan, Michael Zeisberg iD, Susanne S Hille iD, Oliver J Müller und 1 weitere

Cardiovascular Research · 22.05.2026 · 122 (7) · 919-934

DOI: 10.1093/cvr/cvag050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 02.04.2026. Verfasst von Tousif Azmain und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Pneumology, University Medical Center Göttingen, Robert-Koch-Str. 40, Göttingen 37075, Germany. Hauptthemen laut MEDLINE: Basic Helix-Loop-Helix Proteins, Aortic Valve Stenosis, Myofibroblasts, Myocardium. Die Arbeit nennt 81 Literaturangaben. Gefördert von: German Center for Cardiovascular Research, German Research Foundation, Germany's Excellence Strategy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cardiac fibrosis remains a significant and currently untreatable contributor to mortality in chronic heart disease. This study aimed to comprehensively map cell-specific pathological changes in fibrotic heart tissue from aortic stenosis patients using single-nucleus RNA sequencing (snRNA-seq). We specifically sought to identify novel cell-specific candidate genes involved in cardiac fibrosis and validate their functional impact using both in vitro and in vivo models. Our ultimate goal was to enhance the understanding of fibrogenesis in aortic stenosis, thereby guiding the development of targeted antifibrotic therapies. Methods and results We conducted single nucleus RNA sequencing (snRNA-seq) on human fibrotic aortic stenosis and non-failing donor heart samples. The final dataset consisted of 41 330 nuclei distributed across 28 cell clusters representing 6 major cell types. SnRNA-seq revealed a disease-specific subpopulation of fibroblasts, characterized by the presence of both anti-fibrotic and pro-fibrotic markers. Interestingly, TCF21, a basic helix-loop-helix transcription factor, was identified as a potential key regulator within this distinct fibroblast population, and we performed functional studies to identify its role in disease progression accordingly. Loss of TCF21 in cardiac fibroblasts caused increased myofibroblast-like gene expression and differentiation, whereas upregulation of TCF21 in cardiac fibroblasts exerted an anti-fibrotic effect. Adeno-associated virus–mediated cardiac fibroblast-specific knockdown and overexpression in vivo further demonstrate that TCF21 improves cardiac remodelling.

Conclusion

This investigation highlights the role of TCF21 as a protective regulator in cardiac fibrosis. Moreover, the upregulation of TCF21 holds promise as a strategy for treating cardiac fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basic Helix-Loop-Helix ProteinsAortic Valve StenosisMyofibroblastsMyocardiumRNA-SeqCell NucleusFibrosisAnimalsHumansMaleDisease Models, AnimalCells, CulturedSingle-Cell Gene Expression AnalysisFemaleMice, Inbred C57BLMiceSignal Transduction

Stichwörter der Autor:innen

Cardiac fibrosisFibrotic aortic stenosisTCF21snRNA-seq

Substanzen

Basic Helix-Loop-Helix ProteinsTCF21 protein, humanTcf21 protein, mouse

Autor:innen und Institutionen

  • Department of Cardiology and Pneumology, University Medical Center Göttingen, Robert-Koch-Str. 40, Göttingen 37075, Germany.
  • DZHK German Center for Cardiovascular Research, Partner Site Lower Saxony, Robert-Koch-Str. 40, Göttingen 37075, Germany.
  • Cluster of Excellence 'Multiscale Bioimaging: From Molecular Machines to Networks of Excitable Cells' (MBExC), University of Goettingen, Germany.
  • Department of Nephrology and Rheumatology, University Medical Center Göttingen, Robert-Koch-Str. 40, Göttingen 37075, Germany.
  • Department of Internal Medicine V, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • DZHK German Center for Cardiovascular Research, Partner Site Kiel, Arnold-Heller-Str. 3, Kiel 24105, Germany.

ORCID-Profile: Tousif Azmain, Doan Duy Hai Tran, Afifa Binta Saifuddin, Xingbo Xu, Fouzi Alnour, Melanie Hulshoff, Michael Zeisberg, Susanne S Hille

Förderung

  • German Center for Cardiovascular Research
  • German Research Foundation
  • Germany's Excellence Strategy
  • Germany’s Excellence Strategy

Zitieren

APA

Azmain, T., Tran, D. D. H., Saifuddin, A. B., Xu, X., Alnour, F., Hasenfuß, G., Hulshoff, M., Eckhardt, P. L., Tan, X., Zeisberg, M., Hille, S. S., Müller, O. J., & Zeisberg, E. M. (2026). Single nucleus RNA sequencing and functional in vivo studies reveal TCF21 as a protective regulator in cardiac fibrosis. Cardiovascular Research, 122(7), 919-934. https://doi.org/10.1093/cvr/cvag050

Vancouver

Azmain T, Tran DDH, Saifuddin AB, Xu X, Alnour F, Hasenfuß G, et al. Single nucleus RNA sequencing and functional in vivo studies reveal TCF21 as a protective regulator in cardiac fibrosis. Cardiovascular Research. 2026;122(7):919-934. doi:10.1093/cvr/cvag050

BibTeX
@article{Azmain2026,
  author = {Azmain, Tousif and Tran, Doan Duy Hai and Saifuddin, Afifa Binta and Xu, Xingbo and Alnour, Fouzi and Hasenfuß, Gerd and Hulshoff, Melanie and Eckhardt, Phillip L and Tan, Xiaoying and Zeisberg, Michael and Hille, Susanne S and Müller, Oliver J and Zeisberg, Elisabeth M},
  title = {Single nucleus RNA sequencing and functional in vivo studies reveal TCF21 as a protective regulator in cardiac fibrosis},
  journal = {Cardiovascular Research},
  year = {2026},
  volume = {122},
  number = {7},
  pages = {919--934},
  doi = {10.1093/cvr/cvag050}
}
Kostenlos starten →